Pill Connect Releases New Adherence Data
Data demonstrates efficacy of smart dosing technology.
Pill Connect has announced the availability of patient adherence data to support the launch of its Smart Dispenser technology.
In a recent usability study conducted in partnership with major pharma, Smart Dispenser successfully demonstrated dispensing and monitoring at an individual pill-level in real-time without any data upload activity required by the participant. It also highlighted some user acceptance improvements that have been captured in the modified design.
Read more about Pill Connect and its Smart Dispenser technology
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
